4//SEC Filing
Townsend Richard Nolan 4
Accession 0001995218-25-000007
CIK 0001907108other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:21 PM ET
Size
5.4 KB
Accession
0001995218-25-000007
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-11-18$9.27/sh−1,127$10,447→ 240,991 total
Footnotes (3)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Includes 128,357 Restricted Stock Units.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001995218
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:21 PM ET
- Size
- 5.4 KB